Delivery Order SPE2DB22D2206-SPE2DB24FFR47
Award Date 2/16/24
Potential Completion Date 2/20/24
Potential Value $1.1K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply TROKENDI XR 200 MG capsules. The order has a potential value of $2,506.29 and a completion date of February 16, 2024. Amerisourcebergen Drug Corp is the prime contractor and the contract does not have a set-aside designation. This award is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which...
- This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,704.63, is for the delivery of TROKENDI XR 100 MG CAPSULE 30S, a pharmaceutical product. The contract is a Delivery Order type with a Firm Fixed Price pricing structure, and has an ultimate completion date of April 1, 2025. There is no set-aside designation mentioned for this award....
- This federal contract award, valued at $2,251.35, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567985141 - TROKENDI XR 200 MG CAPSULE 30S, a pharmaceutical product. This is a firm fixed-price delivery order contract with an ultimate completion date of April 22, 2025. The contract is not set aside for any specific business category. AmerisourceBergen...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TROKENDI XR 100 MG CAPSULE 30S, a neurological medication, with a ceiling value of $4,648.71 and a period of performance through May 13, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order valued at $2,311.17 for the supply of TROKENDI XR 200 MG CAPSULE 30S. It is a firm fixed price contract with a completion date of July 18, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00 and...
- This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $57,001.99, is for the delivery of TROKENDI XR 100 MG CAPSULE 30S, a specialty medication. The contract has an ultimate completion date of July 17, 2024 and is a firm fixed-price contract type. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
- The Defense Logistics Agency issued a $1,985.51 delivery order to Amerisourcebergen Drug Corp on April 9, 2026, for TROKENDI XR 200 MG capsules (30-count). The order is firm fixed price with an ultimate completion date of April 10, 2026. Place of performance is Conshohocken, PA. The delivery order was issued under the DLA Troop Support Medical IDC (SPE2DX), a $999,999,999 indefinite delivery contract through December 2026 that serves as the primary vehicle for delivering pharmaceutical...
- The Defense Logistics Agency awarded a $1,593.33 delivery order to AmerisourceBergen Drug Corp for TROKENDI XR 50 mg capsules (30-count) on December 3, 2025, with completion due by December 4, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on April 23, 2026, for TROKENDI XR 100 mg capsules with a ceiling value of $3,371.81 under a single-award indefinite delivery contract with the DLA Troop Support Medical program. Place of performance is Conshohocken, PA. The order is firm fixed-price with an ultimate completion date of April 24, 2026. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and operates as a pharmaceutical distributor...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $547.74 delivery order by the Defense Logistics Agency to provide 4562144347 TROKENDI XR 100 MG CAPSULE 30S. The firm fixed price order is being carried out under an existing DLA contract vehicle and will be fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period concluding on September 13, 2023. As the prime contractor, Amerisourcebergen will deliver the...